日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Assessment of MpoxPlex, a high-throughput and multiplexed immunoassay: a diagnostic accuracy study.

对高通量多重免疫测定法 MpoxPlex 的评估:诊断准确性研究

Jones Scott, Hicks Bethany, Callaby Helen, Bailey Daniel, Gordon N Claire, Rampling Tommy, Houlihan Catherine, Jones Rachael, Pond Marcus, Mehta Ravi, Wright Deborah, Oeser Clarissa, Tonge Simon, Linley Ezra, Rowe Cathy, Hallis Bassam, Otter Ashley

Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study - A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines

Com-COV2 研究中异源 COVID 疫苗接种方案的免疫反应持久性——一项包含 mRNA 疫苗、病毒载体疫苗和蛋白佐剂疫苗的单盲随机试验

Shaw, Robert H; Greenland, Melanie; Stuart, Arabella S V; Aley, Parvinder K; Andrews, Nick J; Cameron, J Claire; Charlton, Sue; Clutterbuck, Elizabeth A; Collins, Andrea M; Darton, Tom; Dinesh, Tanya; Duncan, Christopher J A; Faust, Saul N; Ferreira, Daniela M; Finn, Adam; Goodman, Anna L; Green, Christopher A; Hallis, Bassam; Heath, Paul T; Hill, Helen; Lambe, Teresa; Libri, Vincenzo; Lillie, Patrick J; Morey, Ella; Mujadidi, Yama F; Payne, Ruth; Plested, Emma L; Provstgaard-Morys, Samuel; Ramasamy, Maheshi N; Ramsay, Mary; Read, Robert C; Robinson, Hannah; Screaton, Gavin R; Singh, Nisha; Turner, David P J; Turner, Paul J; White, Rachel; Nguyen-Van-Tam, Jonathan S; Liu, Xinxue; Snape, Matthew D

Corrigendum to "Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial" [J Infect 84(6) (2022) 795-813, 5511]

对“在英国接种两剂 ChAdOx1 nCov-19 或 BNT162b2 后,作为第三剂加强针接种的七剂 COVID-19 疫苗的免疫原性持久性:COV-BOOST 试验的三个月分析”的更正 [J Infect 84(6) (2022) 795-813, 5511]

Liu, Xinxue; Munro, Alasdair Ps; Feng, Shuo; Janani, Leila; Aley, Parvinder K; Babbage, Gavin; Baxter, David; Bula, Marcin; Cathie, Katrina; Chatterjee, Krishna; Dejnirattisai, Wanwisa; Dodd, Kate; Enever, Yvanne; Qureshi, Ehsaan; Goodman, Anna L; Green, Christopher A; Harndahl, Linda; Haughney, John; Hicks, Alexander; van der Klaauw, Agatha A; Kwok, Jonathan; Libri, Vincenzo; Llewelyn, Martin J; McGregor, Alastair C; Minassian, Angela M; Moore, Patrick; Mughal, Mehmood; Mujadidi, Yama F; Holliday, Kyra; Osanlou, Orod; Osanlou, Rostam; Owens, Daniel R; Pacurar, Mihaela; Palfreeman, Adrian; Pan, Daniel; Rampling, Tommy; Regan, Karen; Saich, Stephen; Serafimova, Teona; Saralaya, Dinesh; Screaton, Gavin R; Sharma, Sunil; Sheridan, Ray; Sturdy, Ann; Supasa, Piyada; Thomson, Emma C; Todd, Shirley; Twelves, Chris; Read, Robert C; Charlton, Sue; Hallis, Bassam; Ramsay, Mary; Andrews, Nick; Lambe, Teresa; Nguyen-Van-Tam, Jonathan S; Cornelius, Victoria; Snape, Matthew D; Faust, Saul N

Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A randomised controlled trial

青少年接种异源或部分剂量 COVID-19 第二剂疫苗后的反应原性、免疫原性和突破性感染(Com-COV3):一项随机对照试验

Kelly, Eimear; Greenland, Melanie; de Whalley, Philip C S; Aley, Parvinder K; Plested, Emma L; Singh, Nisha; Koleva, Stanislava; Tonner, Sharon; Macaulay, Grace C; Read, Robert C; Ramsay, Mary; Cameron, J Claire; Turner, David P J; Heath, Paul T; Bernatoniene, Jolanta; Connor, Philip; Cathie, Katrina; Faust, Saul N; Banerjee, Indraneel; Cantrell, Liberty; Mujadidi, Yama F; Belhadef, Hanane Trari; Clutterbuck, Elizabeth A; Anslow, Rachel; Valliji, Zara; James, Tim; Hallis, Bassam; Otter, Ashley David; Lambe, Teresa; Nguyen-Van-Tam, Jonathan S; Minassian, Angela M; Liu, Xinxue; Snape, Matthew D

Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial

英国异源和同源新冠疫苗第三剂接种方案后免疫反应的持久性:COV-BOOST试验的八个月分析

Liu, Xinxue; Munro, Alasdair P S; Wright, Annie; Feng, Shuo; Janani, Leila; Aley, Parvinder K; Babbage, Gavin; Baker, Jonathan; Baxter, David; Bawa, Tanveer; Bula, Marcin; Cathie, Katrina; Chatterjee, Krishna; Dodd, Kate; Enever, Yvanne; Fox, Lauren; Qureshi, Ehsaan; Goodman, Anna L; Green, Christopher A; Haughney, John; Hicks, Alexander; Jones, Christine E; Kanji, Nasir; van der Klaauw, Agatha A; Libri, Vincenzo; Llewelyn, Martin J; Mansfield, Rebecca; Maallah, Mina; McGregor, Alastair C; Minassian, Angela M; Moore, Patrick; Mughal, Mehmood; Mujadidi, Yama F; Belhadef, Hanane Trari; Holliday, Kyra; Osanlou, Orod; Osanlou, Rostam; Owens, Daniel R; Pacurar, Mihaela; Palfreeman, Adrian; Pan, Daniel; Rampling, Tommy; Regan, Karen; Saich, Stephen; Saralaya, Dinesh; Sharma, Sunil; Sheridan, Ray; Stokes, Matthew; Thomson, Emma C; Todd, Shirley; Twelves, Chris; Read, Robert C; Charlton, Sue; Hallis, Bassam; Ramsay, Mary; Andrews, Nick; Lambe, Teresa; Nguyen-Van-Tam, Jonathan S; Cornelius, Victoria; Snape, Matthew D; Faust, Saul N

Ethnic differences in cellular and humoral immune responses to SARS-CoV-2 vaccination in UK healthcare workers: a cross-sectional analysis

英国医护人员接种SARS-CoV-2疫苗后细胞和体液免疫反应的种族差异:一项横断面分析

Martin, Christopher A; Nazareth, Joshua; Jarkhi, Amar; Pan, Daniel; Das, Mrinal; Logan, Nicola; Scott, Sam; Bryant, Luke; Abeywickrama, Neha; Adeoye, Oluwatobi; Ahmed, Aleem; Asif, Aqua; Bandi, Srini; George, Nisha; Gohar, Marjan; Gray, Laura J; Kaszuba, Ross; Mangwani, Jitendra; Martin, Marianne; Moorthy, Arumugam; Renals, Valerie; Teece, Lucy; Vail, Denny; Khunti, Kamlesh; Moss, Paul; Tattersall, Andrea; Hallis, Bassam; Otter, Ashley D; Rowe, Cathy; Willett, Brian J; Haldar, Pranab; Cooper, Andrea; Pareek, Manish

Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow-up of two randomized controlled trials

接种两剂 ChAdOx1 nCov-19 (AZD1222) 后免疫反应的持久性:两项随机对照试验的 1 年随访结果

Voysey, Merryn; Flaxman, Amy; Aboagye, Jeremy; Aley, Parvinder K; Belij-Rammerstorfer, Sandra; Bibi, Sagida; Bittaye, Mustapha; Cappuccini, Federica; Charlton, Sue; Clutterbuck, Elizabeth A; Davies, Sophie; Dold, Christina; Edwards, Nick J; Ewer, Katie J; Faust, Saul N; Folegatti, Pedro M; Fowler, Jamie; Gilbride, Ciaran; Gilbert, Sarah C; Godfrey, Leila; Hallis, Bassam; Humphries, Holly E; Jenkin, Daniel; Kerridge, Simon; Mujadidi, Yama F; Plested, Emma; Ramasamy, Maheshi N; Robinson, Hannah; Sanders, Helen; Snape, Matthew D; Song, Rinn; Thomas, Kelly M; Ulaszewska, Marta; Woods, Danielle; Wright, Daniel; Pollard, Andrew J; Lambe, Teresa

Assessment of the Biological Impact of SARS-CoV-2 Genetic Variation Using an Authentic Virus Neutralisation Assay with Convalescent Plasma, Vaccinee Sera, and Standard Reagents

利用康复者血浆、疫苗接种者血清和标准试剂进行真实病毒中和试验,评估SARS-CoV-2基因变异的生物学影响

Coombes, Naomi S; Bewley, Kevin R; Le Duff, Yann; Hurley, Matthew; Smith, Lauren J; Weldon, Thomas M; Osman, Karen; Pullan, Steven; Berry, Neil; Hallis, Bassam; Charlton, Sue; Hall, Yper; Funnell, Simon G P

Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial

在英国开展的一项单盲、随机、II期非劣效性试验(Com-COV2),旨在评估包含mRNA疫苗、病毒载体疫苗和蛋白佐剂疫苗的异源性COVID-19初次免疫接种的免疫原性、安全性和反应原性。

Stuart, Arabella S V; Shaw, Robert H; Liu, Xinxue; Greenland, Melanie; Aley, Parvinder K; Andrews, Nick J; Cameron, J C; Charlton, Sue; Clutterbuck, Elizabeth A; Collins, Andrea M; Darton, Tom; Dinesh, Tanya; Duncan, Christopher J A; England, Anna; Faust, Saul N; Ferreira, Daniela M; Finn, Adam; Goodman, Anna L; Green, Christopher A; Hallis, Bassam; Heath, Paul T; Hill, Helen; Horsington, Bryn M; Lambe, Teresa; Lazarus, Rajeka; Libri, Vincenzo; Lillie, Patrick J; Mujadidi, Yama F; Payne, Ruth; Plested, Emma L; Provstgaard-Morys, Samuel; Ramasamy, Maheshi N; Ramsay, Mary; Read, Robert C; Robinson, Hannah; Screaton, Gavin R; Singh, Nisha; Turner, David P J; Turner, Paul J; Vichos, Iason; White, Rachel; Nguyen-Van-Tam, Jonathan S; Snape, Matthew D

Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial

在接种两剂 ChAdOx1 nCoV-19 或 BNT162b2 疫苗后,再接种第三剂 BNT162b2 疫苗(COV-BOOST),评估 BNT162b2 和 mRNA-1273 COVID-19 疫苗作为第四剂加强针的安全性、免疫原性和反应原性:一项多中心、双盲、II 期随机试验

Munro, Alasdair P S; Feng, Shuo; Janani, Leila; Cornelius, Victoria; Aley, Parvinder K; Babbage, Gavin; Baxter, David; Bula, Marcin; Cathie, Katrina; Chatterjee, Krishna; Dodd, Kate; Enever, Yvanne; Qureshi, Ehsaan; Goodman, Anna L; Green, Christopher A; Harndahl, Linda; Haughney, John; Hicks, Alexander; van der Klaauw, Agatha A; Kanji, Nasir; Libri, Vincenzo; Llewelyn, Martin J; McGregor, Alastair C; Maallah, Mina; Minassian, Angela M; Moore, Patrick; Mughal, Mehmood; Mujadidi, Yama F; Holliday, Kyra; Osanlou, Orod; Osanlou, Rostam; Owens, Daniel R; Pacurar, Mihaela; Palfreeman, Adrian; Pan, Daniel; Rampling, Tommy; Regan, Karen; Saich, Stephen; Bawa, Tanveer; Saralaya, Dinesh; Sharma, Sunil; Sheridan, Ray; Thomson, Emma C; Todd, Shirley; Twelves, Chris; Read, Robert C; Charlton, Sue; Hallis, Bassam; Ramsay, Mary; Andrews, Nick; Lambe, Teresa; Nguyen-Van-Tam, Jonathan S; Snape, Matthew D; Liu, Xinxue; Faust, Saul N